PRAME (preferentially expressed antigen in melanoma), a member of the cancer-testis antigen family, has been reported to be frequently overexpressed in many cancers, including melanoma, which indicates advanced cancer stages and poor clinical prognosis [109,110]. This evidence concerns the gene PRAME and cancer.